NUDT17 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.906800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.913600E-01
Normal-vs-Stage2
7.517200E-01
Normal-vs-Stage3
6.517000E-01
Normal-vs-Stage4
5.199000E-01
Stage1-vs-Stage2
6.723400E-01
Stage1-vs-Stage3
2.178000E-01
Stage1-vs-Stage4
7.378200E-01
Stage2-vs-Stage3
3.487200E-01
Stage2-vs-Stage4
4.438200E-01
Stage3-vs-Stage4
2.163200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.515200E-01
Normal-vs-AfricanAmerican
5.446400E-01
Normal-vs-Asian
6.073200E-01
Caucasian-vs-AfricanAmerican
5.899200E-01
Caucasian-vs-Asian
9.370100E-02
AfricanAmerican-vs-Asian
1.045550E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.946200E-01
Normal-vs-Female
6.954800E-01
Male-vs-Female
6.622000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.003000E-01
Normal-vs-Age(41-60Yrs)
5.340000E-01
Normal-vs-Age(61-80Yrs)
8.053000E-01
Normal-vs-Age(81-100Yrs)
4.917800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.197800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.956600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.175000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.020000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.916800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.599230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.740800E-01
Normal-vs-Daily Drinker
6.683800E-01
Normal-vs-Weekly Drinker
5.858800E-01
Normal-vs-Occasional Drinker
6.772600E-01
Normal-vs-Social Drinker
3.711000E-01
Non Drinker-vs-Daily Drinker
2.795900E-02
Non Drinker-vs-Weekly Drinker
6.517200E-01
Non Drinker-vs-Occasional Drinker
6.600400E-01
Non Drinker-vs-Social Drinker
7.053400E-01
Daily Drinker-vs-Weekly Drinker
1.333440E-01
Daily Drinker-vs-Occasional Drinker
9.199700E-02
Daily Drinker-vs-Social Drinker
9.164000E-03
Weekly Drinker-vs-Occasional Drinker
4.863600E-01
Weekly Drinker-vs-Social Drinker
8.236200E-01
Occasional Drinker-vs-Social Drinker
3.993600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.874800E-01
Normal-vs-Grade 2
5.720200E-02
Normal-vs-Grade 3
2.014800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.952600E-01
Grade 1-vs-Grade 3
5.773000E-01
Grade 1-vs-Grade 4
2.874800E-01
Grade 2-vs-Grade 3
2.489800E-01
Grade 2-vs-Grade 4
5.720200E-02
Grade 3-vs-Grade 4
2.014800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.809400E-01
Normal-vs-NonDiabetic
6.236400E-01
Diabetic-vs-NonDiabetic
7.678000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.033600E-01
Normal-vs-NoPancreatitis
6.821000E-01
Pancreatitis-vs-NoPancreatitis
5.836600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.571800E-01
Normal-vs-N1
7.778800E-01
N0-vs-N1
2.274800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.440400E-01
Normal-vs-TP53-NonMutant
5.513400E-01
TP53-Mutant-vs-TP53-NonMutant
6.901700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
